Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Financial Flexibility Index
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥61.36 Million (operating CF CN¥18.31 Million minus capex CN¥43.04 Million) represents 0% of total liabilities (CN¥2.27 Billion). Check 300497 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangxi Fushine Pharmaceutical Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Jiangxi Fushine Pharmaceutical Co Ltd across 15 annual periods. See working capital to net assets of Jiangxi Fushine Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Jiangxi Fushine Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Jiangxi Fushine Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥287.56 Million | CN¥62.67 Million | CN¥2.20 Billion | ▼ -6.5% |
| 2024 | 0.14x | CN¥329.39 Million | CN¥187.64 Million | CN¥2.36 Billion | ▲ +84.7% |
| 2023 | 0.08x | CN¥177.46 Million | CN¥-64.76 Million | CN¥2.35 Billion | ▼ -47.1% |
| 2022 | 0.14x | CN¥338.56 Million | CN¥-120.85 Million | CN¥2.37 Billion | ▼ -66.4% |
| 2021 | 0.43x | CN¥751.92 Million | CN¥72.32 Million | CN¥1.77 Billion | ▼ -48.9% |
| 2020 | 0.83x | CN¥831.59 Million | CN¥382.35 Million | CN¥997.93 Million | ▲ +34.3% |
| 2019 | 0.62x | CN¥662.81 Million | CN¥337.91 Million | CN¥1.07 Billion | ▲ +91.7% |
| 2018 | 0.32x | CN¥339.80 Million | CN¥175.91 Million | CN¥1.05 Billion | ▼ -14.0% |
| 2017 | 0.38x | CN¥309.72 Million | CN¥210.72 Million | CN¥822.70 Million | ▼ -14.3% |
| 2016 | 0.44x | CN¥269.87 Million | CN¥188.53 Million | CN¥614.20 Million | ▲ +22.9% |
| 2015 | 0.36x | CN¥147.75 Million | CN¥74.01 Million | CN¥413.44 Million | ▲ +49.9% |
| 2014 | 0.24x | CN¥83.25 Million | CN¥31.39 Million | CN¥349.09 Million | ▼ -44.1% |
| 2013 | 0.43x | CN¥132.82 Million | CN¥57.22 Million | CN¥311.55 Million | ▲ +8.7% |
| 2012 | 0.39x | CN¥114.44 Million | CN¥63.20 Million | CN¥291.70 Million | ▼ -21.5% |
| 2011 | 0.50x | CN¥116.01 Million | CN¥33.80 Million | CN¥232.04 Million | — |